Immunostaining revealed that ABCG2 and ALDH1 markers were highly expressed in 76.2% and 80.0% of cancerous tissues as compared to 28% and 33% of benign tumor tissues, respectively. This evidence concerns the gene ABCG2 and neoplasm.